LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.68 | 27.76 | 1333 | 1119 | 1.1912 | 1.0667 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.68 | 27.76 | 18 | 1119 | 0.0161 | -0.0780 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.68 | 27.76 | 1111 | 1119 | 0.9929 | 0.9973 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.39 | 27.76 | 20 | 1305 | 0.0153 | -0.0573 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.39 | 27.76 | 1423 | 1305 | 1.0898 | 1.0312 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.39 | 27.76 | 58 | 1305 | 0.0444 | 0.1418 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.39 | 27.76 | 1173 | 1305 | 0.8984 | 0.9618 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.09 | 27.76 | 24 | 1461 | 0.0164 | -0.0251 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.09 | 27.76 | 1545 | 1461 | 1.0570 | 1.0195 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.09 | 27.76 | 90 | 1461 | 0.0616 | 0.2284 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.09 | 27.76 | 1238 | 1461 | 0.8470 | 0.9428 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 25.79 | 27.76 | 24 | 1605 | 0.0150 | -0.0245 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 25.79 | 27.76 | 1580 | 1605 | 0.9843 | 0.9946 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 25.79 | 27.76 | 224 | 1605 | 0.1396 | 0.4286 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 25.79 | 27.76 | 1321 | 1605 | 0.8230 | 0.9345 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.49 | 27.76 | 40 | 1723 | 0.0232 | 0.0633 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.49 | 27.76 | 1693 | 1723 | 0.9825 | 0.9941 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.49 | 27.76 | 276 | 1723 | 0.1602 | 0.4706 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.49 | 27.76 | 1430 | 1723 | 0.8299 | 0.9384 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.19 | 27.76 | 58 | 1863 | 0.0311 | 0.1291 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.19 | 27.76 | 1857 | 1863 | 0.9967 | 0.9989 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.19 | 27.76 | 293 | 1863 | 0.1573 | 0.4745 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.19 | 27.76 | 1559 | 1863 | 0.8368 | 0.9421 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 30.90 | 27.76 | 62 | 2032 | 0.0305 | 0.1385 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 30.90 | 27.76 | 1953 | 2032 | 0.9610 | 0.9872 | MN20160318_Q01 | C19 |